415 results on '"Poisoning, Accidental -- Care and treatment"'
Search Results
2. Poisoning in children 5: rare and dangerous poisons. (Poisoning)
- Author
-
Riordan, M., Rylance, G., and Berry, K.
- Subjects
Drugs -- Health aspects ,Children -- Care and treatment ,Poisoning, Accidental -- Care and treatment ,Family and marriage ,Health ,Care and treatment - Abstract
Management of children who have ingested β blockers, digoxin, oral hypoglycaemics, organophosphates, carbon monoxide, cyanide, isopropanol, ethylene glycol, methanol, Ecstasy, LSD, cocaine, nicotine, and isoniazid In the final paper in [...]
- Published
- 2002
3. Poisoning in children 4: household products, plants, and mushrooms. (Poisoning)
- Author
-
Riordan, M., Rylance, G., and Berry, K.
- Subjects
Cleaning compounds -- Health aspects ,Poisonous plants -- Health aspects ,Children -- Health aspects ,Poisoning, Accidental -- Care and treatment ,Family and marriage ,Health ,Care and treatment ,Health aspects - Abstract
Management of children who have ingested bleach, white spirit, turpentine, general household cleaning products, alcohol, rodenticides, petrochemicals, essential oils, vapour treatments, nail care products, and washing powder; and also poisonous [...]
- Published
- 2002
4. Ingestion of toxic substances by children
- Author
-
Shannon, Michael
- Subjects
Poisoning, Accidental -- Care and treatment ,Sick children -- Care and treatment - Abstract
The management of accidental poisoning in children is discussed. Gastric lavage and ipecac syrup should be used to remove the toxic chemical from the child's stomach. The child can be given activated charcoal to adsorb the chemical. Cathartic agents can be used to increase gastrointestinal movement and allow the the gastrointestinal system to excrete the chemical. Childhood poisonings have decreased substantially since the creation of child-proof containers for drugs and other hazardous substances. Cosmetics, personal care products and cleaning products are the most common substances swallowed by young children.
- Published
- 2000
5. Aconite poisoning
- Author
-
Chan, Thomas Y.K.
- Subjects
Poisoning, Accidental -- Care and treatment ,Poisoning, Accidental -- Causes of ,Poisoning, Accidental -- Complications and side effects ,Neurotoxic agents -- Health aspects ,Medicine, Botanic -- Complications and side effects ,Medicine, Herbal -- Complications and side effects ,Environmental issues ,Health ,Pharmaceuticals and cosmetics industries - Published
- 2009
6. Death on the ward: something was killing scores of Panamanians. Was it a new virus? The answer would shock the world
- Author
-
Mullens, Anne
- Subjects
Poisoning, Accidental -- Diagnosis ,Poisoning, Accidental -- Care and treatment ,Poisoning, Accidental -- Patient outcomes ,Drug adulteration -- Cases ,Antitussive agents -- Contamination ,Company legal issue ,General interest - Published
- 2008
7. Improvement in the management of acutely poisoned patients using an electronic database, prospective audit and targeted educational intervention
- Author
-
Greene, S.L., Wood, D.M., Gawarammana, I.B., Warren-Gash, C., Drake, N., Jones, A.L., and Dargan, P.I.
- Subjects
Poisoning, Accidental -- Care and treatment ,Poisoning, Accidental -- Management ,Poisoning, Accidental -- Research ,Database administration -- Research ,Emergency medical services -- Research ,Company business management ,Health - Published
- 2008
8. Responding to pediatric poisoning
- Author
-
Madden, Maureen A.
- Subjects
Poisoning, Accidental -- Prevention ,Poisoning, Accidental -- Care and treatment ,Nursing care -- Methods ,Health - Abstract
The author discusses the common causes of pediatric poisoning due to ingestion of toxic substances. Nurses are advised on the best methods to deal with individual cases and safety tips are recommended to parents to prevent accidental ingestion.
- Published
- 2008
9. N-acetylcysteine and hemodialysis treatment of a severe case of methyl ethyl ketone peroxide intoxication
- Author
-
van Enckevort, C.C.G., Touw, D.J., and Vleming, L.-J.
- Subjects
Acetylcysteine -- Dosage and administration ,Hemodialysis -- Dosage and administration ,Acidosis -- Care and treatment ,Formic acid -- Health aspects ,Methyl ethyl ketone -- Health aspects ,Poisoning, Accidental -- Care and treatment ,Poisoning, Accidental -- Case studies ,Environmental issues ,Health ,Pharmaceuticals and cosmetics industries - Published
- 2008
10. Oral C-4 plastic explosives in humans - a case series
- Author
-
Davies, James O.J., Roberts, Darren M., Hittarage, Ariyasena, and Buckley, Nick A.
- Subjects
Explosives -- Health aspects ,Explosives -- Case studies ,Poisoning, Accidental -- Care and treatment ,Convulsions -- Causes of ,Convulsions -- Care and treatment ,Benzodiazepines -- Dosage and administration ,Environmental issues ,Health ,Pharmaceuticals and cosmetics industries - Published
- 2007
11. A comparison of cathartics in pediatric ingestions
- Author
-
James, Laura Phillips, Nichols, Michele H., and King, William D.
- Subjects
Poisoning, Accidental -- Care and treatment ,Laxatives -- Evaluation ,Sorbitol -- Health aspects - Abstract
The use of sorbitol after childhood poisoning may be more effective than other treatments. Sorbitol is a laxative often given in combination with activated charcoal to cleanse the system of toxic agents. Researchers compared the effect of sorbitol, magnesium citrate, magnesium sulfate, or water in 116 small children. Poison center staff contacted parents or nurses of each patient in regular intervals up to 24 hours after treatment. A total of 32 patients received sorbitol infusions. Sorbitol produced first stools in less than 8.5 hours and an average of 2.97 stools. The other treatments resulted in later and fewer stools as reported by telephone. For example, magnesium citrate produced a stool after 12.84 hours. Vomiting was the most common side effect after cathartic treatment in all groups but happened predominantly in the group receiving sorbitol., Objective. To compare the mean time to first stool, number of stools, and side effects of three commonly used cathartics in pediatric ingestions. Design. This prospective clinical trial was a randomized, double-blinded comparison of sorbitol, magnesium citrate, magnesium sulfate, and water, administered with activated charcoal in the treatment of pediatric patients 1 to 5 years of age with acute ingestions. Outcome parameters were mean time to first stool, mean number of stools during 24 hours, and side effects. Results. One hundred sixteen patients completed the study. Significant differences in mean time to the first stool were detected among cathartic agents (F = 9.29), with sorbitol-treated patients having a shortest mean time to the first stool (mean, 8.48 hours). Sorbitol produced a significantly higher number of stools (mean, 2.79) in the 24-hour follow-up period than other cathartics (F = 3.49). The most common side effect of cathartic administration was emesis, which occurred more commonly in sorbitol-treated patients. Conclusion. Sorbitol, when administered with activated charcoal in the treatment of children with acute ingestions, produced a shorter time to first stool and more stools than magnesium citrate, magnesium sulfate, or water. Pediatrics 1995; 96:235-238; cathartics, poisoning, sorbitol, charcoal, decontamination, ingestions., ABBREVIATIONS. TCHA, The Children's Hospital of Alabama; ANOVA, analysis of variance; LSD, least-significant difference; [x.sub.adj'] mean adjusted; [x.sub.init'] mean initial. Cathartics are frequently administered with activated charcoal in the management [...]
- Published
- 1995
12. Pediatric poisoning! Quick action can save a child's life when she presents with suspected poisoning. Well-timed advice on how to keep kids safe in the first place can save countless others the harrowing experience
- Author
-
Broderick, Molly
- Subjects
Poisoning, Accidental -- Care and treatment ,Poisons -- Safety and security measures ,Children -- Injuries ,Children -- Diagnosis ,Children -- Care and treatment ,Children -- Prevention ,Health - Abstract
The young mother heard a cry and ran into the kitchen to find her 18-month-old daughter on the floor next to a spilled container of liquid drain opener. The toddler [...]
- Published
- 2004
13. Arsenic in a child's world
- Author
-
Pike-Paris, Ann
- Subjects
Diarrhea in children -- Causes of ,Pediatric nursing -- Case studies ,Poisoning, Accidental -- Care and treatment ,Poisoning, Accidental -- Diagnosis ,Poisons -- Safety and security measures ,Arsenic -- Health aspects - Abstract
Ten-year-old Tim P. presented at a local emergency room complaining of bloody diarrhea. Despite treatment, his diarrhea continued with additional symptoms of nausea, raspy voice, headaches, abdominal pain, tingling of the feet and hands, lethargy, and eczema. Do you recognize the health risks and clinical aspects of arsenic, and could you assist Tim and his family?, Environmental exposure in our children's world to known and unknown toxins is an evolving area of concern and research. Over the past several years the heavy metal arsenic (As) has [...]
- Published
- 2004
14. Accidental poisoning with autumn crocus
- Author
-
Gabrscek, Lucija, Lesnicar, Gorazd, Krivec, Bojan, Voga, Gorazd, Sibanc, Branko, Blatnik, Janja, and Jagodic, Boris
- Subjects
Poisoning -- Care and treatment ,Poisoning -- Case studies ,Colchicum -- Risk factors ,Colchicum -- Case studies ,Colchicine -- Risk factors ,Poisoning, Accidental -- Care and treatment ,Poisoning, Accidental -- Case studies ,Environmental issues ,Health ,Pharmaceuticals and cosmetics industries - Abstract
We describe a case of a 43-yr-old female with severe multiorgan injury after accidental poisoning with Colchicum autumnale, which was mistaken for wild garlic (Allium ursinum). Both plants grow on damp meadows and can be confused in the spring when both plants have leaves but no blossoms. The autumn crocus contains colchicine, which inhibits cellular division. Treatment consisted of supportive care, antibiotic therapy, and granulocyte-directed growth factor. The patient was discharged from the hospital after three weeks. Three years after recovery from the acute poisoning, the patient continued to complain of muscle weakness and intermittent episodes of hair loss., INTRODUCTION Autumn crocus (Colchicum autumnale) and wild garlic (Allium ursinum), both members of the same subclass (Liliidae), have very similar leaves that can easily be mistaken for each other during [...]
- Published
- 2004
15. Poison centers, poison prevention, and the pediatrician
- Author
-
Lovejoy, Frederick H., Jr., Robertson, William O., and Woolf, Alan D.
- Subjects
Poisons -- Safety and security measures ,Children's accidents -- Prevention ,Poison control centers -- Evaluation ,Poisoning, Accidental -- Care and treatment - Abstract
Enormous progress has been made in the field of toxicology, poison prevention, and poison treatment since the establishment of the first poison center 40 years ago. There are now more than 38 certified regional centers and 48 other centers, many of which are in the process of becoming certified. These centers provide access to information on over 800,000 products and 12.5 million cases of poisoning. They also act as referral centers, help coordinate care of poison victims and the agencies involved in such care, and act as centers for research as well as poison prevention education and professional training. They help reduce health care costs by reducing the number of unnecessary emergency room visits and by decreasing illness from delayed care. Challenges for the future include limited funds, new household products entering the market, and improving services., ABSTRACT. The first poison centers were established in the United States in the early 1950s, stimulated by an American Academy of Pediatrics' survey of office-based pediatric practices which ascertained that its members had no place to turn for ingredient information on medications and household products.[1] With the help of the Academy, pediatrician Dr. Edward Press, the Illinois Department of Health, and several community hospitals, the first poison center emerged. Over the subsequent 40 years, remarkable progress has occurred in the fields of clinical toxicology, poison control, and poison prevention. Yet despite these accomplishments, challenging clouds are appearing on the horizon which threaten these gains. This commentary, by the authors who have viewed and participated in a large part of the history of this progress, will focus on these major accomplishments with an emphasis on (a) poison prevention utilizing the pre-event (primary prevention), (b) the event (secondary prevention), and (c) the postevent tertiary prevention) model.[2]
- Published
- 1994
16. Carbamate poisoning and oxime treatment in children: a clinical and laboratory study
- Author
-
Lifshitz, Matitiahu, Rotenberg, Michal, Sofer, Shaul, Tamiri, Tsippy, Shahak, Eliezer, and Almog, Shlomo
- Subjects
Carbamates -- Health aspects ,Poisoning, Accidental -- Care and treatment ,Antidotes -- Evaluation - Abstract
Oxime therapy appears to have no benefit in cases of carbamate poisoning in children. However, if the poison is not identified or in cases of mixed poisons, oxime therapy may be safely used. Carbamates, such as aldicarb and methomyl, are used in pesticides. Oximes are effective in treating organophosphate poisoning, but are not recommended for carbamate poisoning because animal studies have indicated they could increase the toxicity. Researchers reviewed the medical records of 26 children from one to eight years old who were hospitalized because of suspected organophosphate poisoning. They were all treated with the antidote atropine sulfate, and also with the oxime obidoxime chloride. The children all improved and had no ill effects from the oxime. Later analysis of the pesticides proved that all the children had been poisoned with carbamates. Laboratory tests showed that oximes do not reactivate the enzyme inhibited by carbamates, so they could have no therapeutic benefit in carbamate poisoning., Objective. (1) Retrospective evaluation of the clinical course of carbamate poisoning and the effect of oxime therapy in children. (2) In vitro study of the effect of oximes on the reactivation of carbamylated cholinesterase. Design. (1) Clinical survey: The records of 26 children intoxicated with carbamates were examined retrospectively. The poisoning agents in all cases were positively identified as methomyl or aldicarb by gas chromatography-mass spectrometry. (2) Laboratory study: The direct effect of obidoxime and of pralidoxime on acetylcholinesterase activity in vitro was investigated in normal human packed red blood cells pretreated with an organophosphate (paraoxon) or a carbamate (aldicarb or methomyl). Clinical setting. Pediatric intensive care unit of a teaching hospital. Patients. Twenty-six infants and young children (aged 1 to 8 years) admitted to the pediatric intensive care unit with severe carbamate intoxication. Interventions. All cases had been treated with repeated doses of atropine sulfate (0.05 mg/kg) administered every 5 to 10 minutes until muscarinic symptoms disappeared. Obidoxime chloride (Toxogonin, 6 mg/kg) was administered on admission, and again after 4 to 5 hours. Results. Predominant symptoms were related to central nervous system and nicotinic effects. All the patients showed marked improvement within several hours and recovered completely within 24 hours. None of the children deteriorated and none showed exacerbation of cholinergic symptoms after obidoxime treatment. In vitro, oximes reactivated acetylcholinesterase inhibited with paraoxon, whereas no significant effect of oximes on carbamylated enzyme activity was observed. Conclusions. Based on the recovery of all cases, as compared with other reports of carbamate poisoning treated with atropine alone, it is concluded that, in the case of aldicarb or methomyl poisoning, oxime therapy apparently does not contribute to the recovery of poisoned patients. In cases of poisoning by an unknown pesticide or of mixed poisoning, oxime therapy can prove beneficial because no negative effects of the therapy can be discerned. Pediatrics 1994,93:652-655; carbamate intoxication in children; oxime therapy; erythrocyte cholinesterase inhibition.
- Published
- 1994
17. Status epilepticus from an illegally imported chinese rodenticide: 'tetramine'
- Author
-
Barrueto, Fermin, Jr., Furdyna, Peter M., Hoffman, Robert S., Hoffman, Robert J., and Nelson, Lewis S.
- Subjects
Pediatric toxicology -- Case studies ,Poisoning, Accidental -- Care and treatment ,Rodenticides -- Health aspects ,Status epilepticus -- Causes of ,Environmental issues ,Health ,Pharmaceuticals and cosmetics industries - Abstract
Introduction: The following case report demonstrates the severe consequences of refractory convulsive status epilepticus from an unfamiliar imported toxin, tetramethylenedisulfotetramine (TETS), and the difficulties of identifying the offending agent. Case Report: A previously healthy 15-month-old girl was found by her parents playing with a white rodenticide powder brought from China. Fifteen minutes later, the child developed generalized seizures and was brought to an Emergency Department (ED). Her initial fingerstick blood glucose was 108 mg/dL. In the ED, the child was intubated for status epilepticus. Despite aggressive therapy with lorazepam, phenobarbital, and pyridoxine, she had 4 h of intermittent generalized seizure activity. She was extubated on the third hospital day, but appeared to have absence seizures and cortical blindness. Continuous electroencephalogram monitoring, performed weeks later, revealed severe diffuse cerebral dysfunction with multiple epileptogenic foci. The child remains developmentally delayed and is on valproic acid therapy for seizure control. Translation of the Chinese package labeling did not clarify its contents. Tetramethylenedisulfotetramine was finally confirmed by gas chromatography-mass spectrometry (GC-MS) in this rodenticide product and then quantified against a TETS standard that was synthesized in our laboratory. Conclusion: Tetramethylenedisulfotetramine is grouped with other 'cage convulsants,' such as picrotoxin, since they have a similar intercalating cyclical molecular structure and cause seizures through non-competitive [gamma]-aminobutyric acid (GABA) antagonism. The oral lethal dose 50% (LD50) in humans is estimated to be as low as 100 [micro]g/kg. Our patient has severe diffuse cerebral dysfunction likely secondary to prolonged seizure activity after exposure to TETS. Key Words: Cage convulsant; Tetramine; Seizures; Status epilepticus., INTRODUCTION Seizures are caused by a multitude of toxins although few have a propensity to cause status epilepticus. Most patients with status epilepticus present with brief episodes of convulsions intermixed [...]
- Published
- 2003
18. Guideline for the out-of-hospital management of human exposures to minimally toxic substances #
- Author
-
McGuigan, Michael A.
- Subjects
Pediatric toxicology -- Care and treatment ,Poisoning, Accidental -- Care and treatment ,Environmental issues ,Health ,Pharmaceuticals and cosmetics industries ,American Association of Poison Control Centers -- Standards - Abstract
GUIDELINE SUMMARY All substances are capable of producing toxicity, so nothing is completely non-toxic. Minimally toxic substances are those which produce little toxicity, minor self-limited toxicity, or clinically insignificant effects at most doses. Examples include silica gel, A&D ointment, chalk, lipstick, and non-camphor lip balms, watercolors, hand dishwashing detergents, non-salicylate antacids (excluding magnesium or sodium bicarbonate containing products), calamine lotion, clay, crayons, diaper rash creams and ointments, fabric softeners/sheets, glow products, glue (white, arts, and crafts type), household plant food, oral contraceptives, pen ink, pencils, starch/sizing, throat lozenges without local anesthetics, topical antibiotics, topical antifungals, topical steroids, topical steroids with antibiotics, and water-based paints. Minimally toxic exposures have the following characteristics: (1) The information specialist has confidence in the accuracy of the history obtained and the ability to communicate effectively with the caller. (2) The information specialist has confidence in the identity of the product(s) or substance(s) and a reasonable estimation of the maximum amount involved in the exposure. (3) The risks of adverse reactions or expected effects are acceptable to both the information specialist and the caller based on available medical literature and clinical experience. (4) The exposure does not require a healthcare referral since the potential effects are benign and self-limited. However, decisions regarding patient disposition should take into account the patient's intent, symptoms, and social environment. In addition, individual patient circumstances (e.g., pregnancy, pre-existing medical conditions, therapeutic interventions) need to be considered. Minimally toxic exposures may vary in route (dermal, inhalation, ingestion, ocular), chronicity (acute, chronic), and substance composition (single or multi-ingredient, single or multiple product). Future categorization of substances as 'minimally toxic' should be based on a process involving review of current knowledge, a thorough analysis of poisoning experience, and prospective validation. Key Words: Poisoning; Triage; Guideline; Minimally toxic substance; Poison center., PREAMBLE This document describes the characteristics of and process for determining a minimally toxic exposure. The primary purpose of this document is to assist poison center directors and information specialist [...]
- Published
- 2003
19. Hydrofluoric acid-induced burns and life-threatening systemic poisoning--favorable outcome after hemodialysis
- Author
-
Bjornhagen, V., Hojer, J., Karlson-Stiber, C., Selden, A.I., and Sundbom, M.
- Subjects
Burns and scalds -- Care and treatment ,Hydrofluoric acid -- Accidents ,Poisoning, Accidental -- Care and treatment ,Environmental issues ,Health ,Pharmaceuticals and cosmetics industries - Abstract
Background: Skin contact with hydrofluoric acid (HF) may cause serious burns and life-threatening systemic poisoning. The use of hemodialysis in fluoride intoxication after severe dermal exposure to HF has been recommended but not reported. Case report: A 46-year-old previously healthy man had 7% of his body surface exposed to 71% HF. Despite prompt management, with subsequent normalization of the serum electrolytes, recurrent ventricular fibrillation occurred. On clinical suspicion of fluoride-induced cardiotoxicity, acute hemodialysis was performed. The circulatory status stabilized and the patient fully recovered. High fluoride levels in the urine and serum were confirmed by the laboratory. Discussion: There is no ultimate proof that the favorable outcome in this case was significantly attributable to the dialysis. However, most reported exposures of this magnitude have resulted in fatal poisoning. As our patient had normal serum electrolytes and no hypoxia or acidosis at the time of his arrhythmias, it was decided that all efforts should be focused on removing fluoride from his blood. The rationale for performing hemodialysis for this purpose is clear, even though such intervention is more obviously indicated in patients with renal failure. Conclusion: Hemodialysis may be an effective and potentially lifesaving additional treatment for severe exposure to HF when standard management has proven insufficient. Key Words: Dermal exposure; Fluoride intoxication; Hemodialysis; Hydrofluoric acid., INTRODUCTION Hydrofluoric acid (HF) is a highly corrosive inorganic acid that is used widely in the etching and frosting of glass and pickling of metals; in manufacture of graphite and [...]
- Published
- 2003
20. Ephedrine-induced cardiac ischemia: exposure confirmed with a serum level (#)
- Author
-
Schier, Joshua G., Traub, Stephen J., Hoffman, Robert S., and Nelson, Lewis S.
- Subjects
Dietary supplements -- Adverse and side effects ,Ephedrine -- Adverse and side effects ,Poisoning, Accidental -- Care and treatment ,Environmental issues ,Health ,Pharmaceuticals and cosmetics industries - Abstract
The temporal association of symptoms consistent with ephedrine toxicity after ingestion of ephedrine-containing dietary supplements is heavily relied upon to confirm exposure. Few reports in the literature attempt to associate toxicity with serum levels of these drags. We report a case of ephedrine-induced cardiac ischemia confirmed by a plasma level. A 22-year-old woman ingesting an ephedrine- and caffeine-containing product for 2 days presented with multiple symptoms, including palpitations, nausea, tremulousness, abdominal pain, and vomiting. The initial electrocardiogram (ECG) revealed a normal sinus rhythm with 1 mm of ST segment depression in leads V3 and V4, along with inverted T waves in leads V1-V4. Her symptoms and ST segment depression resolved over several hours with medical management. The amplitude of her T wave inversions notably diminished with therapy; however, they did not completely resolve. Troponins at presentation and the following morning were negative, and an echocardiogram showed only trace tricuspid regurgitation. A serum ephedrine level, drawn approximately 6 to 7 hr after ingestion, was 150 ng/mL. She was discharged from the hospital after being instructed to avoid ephedrine-containing products. Key Words: Ephedrine; Cardiac; Ischemia., INTRODUCTION Ma huang, an herbal source of ephedrine, is a common ingredient of many dietary supplements sold as stimulants, weight reduction aids, or athletic performance enhancers. It is estimated that [...]
- Published
- 2003
21. Acute Poisonings with Breynia officinalis--an outbreak of hepatotoxicity
- Author
-
Lin, Tzeng-Jih, Su, Ching-Chyuan, Lan, Chi-Kin, Jiang, Donald-D, Tsai, Jin-Lian, and Tsai, Mee-Sun
- Subjects
Poisoning, Accidental -- Care and treatment ,Euphorbiaceae -- Adverse and side effects ,Environmental issues ,Health ,Pharmaceuticals and cosmetics industries - Abstract
Background. In combination with other traditional Chinese medicines, Breynia officinalis, a species of Euphorbiaceae, has long been used to treat contusions, heart failure, venereal diseases, growth retardation, and conjunctivitis. B. officinalis, regarded as a poison, was mistaken for a similar plant, Securinega suffruticosa, and cooked in a soup used for the treatment of muscle soreness, lumbago, and as a tonic in this outbreak. Case series. Nineteen patients, 11 males and 8 females (average age 49.2 [+ or -] 9.1 years) consumed an average of 130 mL (30-900mL) of soup containing B. officinalis stems. Fourteen patients developed diarrhea, 10 experienced nausea and chilly sensations, 9 had sensations of abdominal fullness, and 7 suffered from vomiting. The results of liver function tests (LFTs) indicated that the observed maximum median level of alanine aminotransferase (ALT) was 647 U/L (range 89-9440 U/L), aspartate aminotransferase (AST) 314 U/L (range 47-7756 U/L), alkaline phosphatase 251 U/L (range 224-278 U/L), and gamma glutamyl transpeptidase 106 U/L (range 84-313 U/L). The median time to the observed median peak levels was 3 days for ALT, 2 days for AST, 5 days for alkaline phosphatase, and 12 days for gamma glutamyl transpeptidase. With supportive treatment, the majority of abnormalities in 14 of the cases resolved within 6 months of exposure. Conclusions. The consumption of a soup containing B. officinalis Hemsley resulted in dose-related toxic effects. Clinical toxicity consisted primarily of gastrointestinal symptoms and signs and hepatotoxicity. Hepatocellular liver injury rather than cholestatic liver injury was observed. Marked jaundice did not develop. Key Words: Breynia officinalis; Hepatotoxicity., INTRODUCTION Breynia officinalis, a species of Euphorbiaceae, carries the Chinese proprietary name 'Chi R Yun,' which means 'dizziness or vertigo for 7 days.' In daily practice, it has been used [...]
- Published
- 2003
22. Plasma salicylate from methyl salicylate cream compared to oil of wintergreen
- Author
-
Wolowich, William R., Hadley, Carmen M., Kelley, Michael T., Walson, Phillip D., and Casavant, Marcel J.
- Subjects
Poisoning, Accidental -- Care and treatment ,Environmental issues ,Health ,Pharmaceuticals and cosmetics industries - Abstract
Background. Poison Control Centers follow the acetylsalicylic acid (ASA) treatment guideline to manage unintentional ingestions of topical methyl salicylate liniments. For example, one teaspoon of 30% methyl salicylate cream such as Ben Gay[R] provides an 'ASA equivalent dose' of 180 mg/kg for a 10 kg child. The ASA treatment guideline advises emesis with syrup of Ipecac and 24 h home followup for this dose. Both the ASA conversion factor to yield the ASA equivalent dose and the treatment guideline assume 100% bioavailability of the salicylate. The nature of this topical dosage product led the investigators to expect less than complete absorption of methyl salicylate. Objective. To compare plasma concentrations of salicylate from ingested methyl salicylate cream with plasma concentrations of salicylate from ingested oil of wintergreen. Methods. Four adult volunteers consented to an open label, four-way crossover design, with randomization to the following treatments: 1 mL Oil of Wintergreen, U.S.P., 6.7 g of Ben Gay[R] 15% and 20 g of Ben Gay[R] 15% and also to hold 5 g of Ben Gay[R] 15% cream in the buccal cavity for 1 minute and then expectorate. Plasma was collected for salicylate determination, and the results analyzed with a noncompartmental pharmacokinetic model. Results. No plasma salicylate was detected after buccal treatment phase. Relative bioavailability for the low-dose treatment was 0.5 compared to oil of wintergreen. Conclusion. Plasma salicylate concentrations from methyl salicylate cream are not equal to those achieved after ingestion of oil of wintergreen. Dosage formulation must be considered when predicting toxicity. Key Words: Salicylate; Methyl salicylate; Oil of wintergreen; Pharmacokinetics; Bioavailability., INTRODUCTION Methyl salicylate is on the short list of medicines causing pediatric death in small doses (1-3). The high morbidity and mortality is caused by a form of methyl salicylate [...]
- Published
- 2003
23. Acute plant poisoning and antitoxin antibodies. (Antivenoms)
- Author
-
Eddleston, Michael and Persson, Hans
- Subjects
Antitoxins -- Supply and demand ,Poisoning, Accidental -- Care and treatment ,Poisonous plants -- Health aspects ,Poison control centers -- Equipment and supplies ,Environmental issues ,Health ,Pharmaceuticals and cosmetics industries - Abstract
Plant poisoning is normally a problem of young children who unintentionally ingest small quantities of toxic plants with little resulting morbidity and few deaths. In some regions of the world, however, plant poisonings are important clinical problems causing much morbidity and mortality. While deaths do occur after unintentional poisoning with plants such as Atractylis gummifera (bird-lime or blue thistle) and Blighia sapida (ackee tree), the majority of deaths globally occur following intentional self-poisoning with plants such as Thevetia peruviana (yellow oleander) and Cerbera manghas (pink-eyed cerbera or sea mango). Antitoxins developed against colchicine and cardiac glycosides would be useful for plant poisonings--anti-digoxin Fab fragments have been shown to be highly effective in T. peruviana poisoning. Unfortunately, their great cost limits their use in the developing world where they would make a major difference in patient management. Therapy for some other plant poisonings might also benefit from the development of antitoxins. However, until issues of cost and supply are worked out, plant antitoxins are going to remain a dream in many of the areas where they are now urgently required., INTRODUCTION Globally, plants are an uncommon cause of significant poisoning. However, unintentional poisoning with plants is common in small children. Surveys of calls to Poison Information Centres in Germany and [...]
- Published
- 2003
24. Evaluation of the time frame for home ipecac syrup use when not kept in the home
- Author
-
Garrison, James, Shepherd, Greene, Huddleston, William L., and Watson, William A.
- Subjects
Poisoning, Accidental -- Care and treatment ,Ipecac (Drug) -- Dosage and administration ,Environmental issues ,Health ,Pharmaceuticals and cosmetics industries - Abstract
Introduction. The home administration of ipecac syrup remains a recommendation in some guidelines for the management of specific pediatric poisonings. A common challenge for poison specialists is how to approach the situation when ipecac syrup is indicated but not kept in the home. This study examines whether or not ipecac syrup can be administered and produce timely emesis in this situation. Methods. Over a 6-month period, a prospective observational study was undertaken to determine if ipecac syrup can be administered in a timely manner when it is indicated but not available in the home. Cases where ipecac syrup was indicated but not kept in the home were included if parents stated that they could obtain ipecac within 15 minutes. Timely administration and the onset of emesis were defined as Key Words: Poisoning; Ipecac, Poison centers; Telemedicine., INTRODUCTION Although its use is decreasing, the home administration of ipecac syrup is still recommended by many poison centers for the management of specific pediatric poisonings (1). A challenge facing [...]
- Published
- 2003
25. Street-smart advice on treating drug overdoses
- Author
-
Soloway, Rose Ann Gould
- Subjects
Drugs -- Overdose ,Poisoning, Accidental -- Care and treatment ,Health - Published
- 1993
26. Pediatric poisonings: the 10 most toxic prescription drugs
- Author
-
Morelli, James
- Subjects
Pediatric toxicology -- Analysis ,Poisons -- Physiological aspects ,Poisoning, Accidental -- Care and treatment ,Health - Published
- 1993
27. Liquid mercury: a poisonous plaything. (Liquid Mercury)
- Author
-
Amler, Sherlita
- Subjects
Mercury -- Health aspects ,Poisoning, Accidental -- Care and treatment - Abstract
Faced with a child who has been exposed to mercury, would you recognize the signs and symptoms? Would you know what questions to ask, which lab tests to draw, and [...]
- Published
- 2002
28. A prospective study of acute, unintentional, pediatric superwarfarin ingestions managed without decontamination. (Pediatrics)
- Author
-
Ingels, Marianne, Lai, Chi, Tai, Winnie, Manning, Beth H., Rangan, Cyrus, Williams, Saralyn R., Manoguerra, Anthony S., Albertson, Timothy, and Clark, Richard F.
- Subjects
Poisoning, Accidental -- Care and treatment ,Children's accidents -- Care and treatment ,Health - Published
- 2002
29. Children and adolescents with acute alcohol intoxication/self-poisoning presenting to the emergency department. (Article)
- Author
-
Woolfenden, Sue, Dossetor, David, and Williams, Katrina
- Subjects
Alcohol -- Health aspects ,Children -- Alcohol use ,Alcohol and youth -- Research ,Poisoning, Accidental -- Care and treatment ,Health - Abstract
Objectives To describe the presentations, characteristics, and follow-up care of children and adolescents aged 10 to 18 years who present to emergency departments (EDs) with acute alcohol intoxication/self-poisoning. Design: Retrospective medical record review. Setting: Five EDs in Western Sydney, Australia. Participants: Patients aged 10 to 18 years who presented to EDs with acute alcohol intoxication/self-poisoning between January 1, 1996, and December 31, 2000. Main Outcome Measures: Frequency of presentations; presentation characteristics; psychosocial characteristics; and presence or absence of follow-up. Results: Two hundred twelve children and adolescents presented to EDs 216 times. Of the 212 patients, 49 (23%) were 14 years or younger, and the youngest was aged 10 years. The majority (82%) came after hours and were brought in by emergency services (77%). In 13% of presentations, verbal and/or physical aggression was present, and a threat of self-harm was present in 2% of cases. A mental health worker was consulted about the child or adolescent in only 6% of presentations. Most children and adolescents (85%) were discharged from the ED. Of concern, in 56% of presentations, a follow-up plan was not recorded. There was documentation of mental health follow-up in only 14% of presentations and follow-up from drug and alcohol services in only 1%. Forensic history, school functioning, and a history of past mental health problems were not documented in more than 60% of the medical records examined. Conclusions: When children or adolescents present to an ED with acute alcohol intoxication/self-poisoning, their risk factors for psychosocial dysfunction appear to be inadequately assessed, documented, and followed up. Clear guidelines for assessment and referral pathways must be established in EDs. Arch Pediatr Adolesc Med. 2002;156:345-348
- Published
- 2002
30. Randomized placebo-controlled trial of 2,3-dimercapto-1-propanesulfonate (DMPS) in therapy of chronic arsenicosis due to drinking arsenic-contaminated water. (Metals)
- Author
-
Mazumder, Debendra Nath Guha, De, Binay Krishna, Santra, Amal, Ghosh, Nilima, Das, Subhankar, Lahiri, Sarbari, and Das, Tapas
- Subjects
Arsenic -- Health aspects ,Poisoning, Accidental -- Care and treatment ,Drinking water -- Contamination ,Environmental issues ,Health ,Pharmaceuticals and cosmetics industries - Abstract
Background: Chronic arsenic toxicity, producing various clinical manifestations, is currently epidemic in West Bengal, India, Bangladesh, and other regions of the world. 2,3-Dimercapto-1-propanesulfonate, a chelating agent, increases excretion of arsenic in urine to several times the prechelation concentration but the therapeutic efficacy of 2,3-dimercapto-1-propanesulfonate in the management of chronic arsenic toxicity has been incompletely evaluated. We investigated the clinical use of 2,3-dmercapto-1-propanesulfonate in such patients. Methods: Twenty-one consecutive patients with chronic arsenicosis were individually randomized into 2 groups: 11 patients (9 males and 2 females, age 30.63 [+ or -] 11.4 years) received 2,3-dimercapto-1-propanesulfonate 100-mg capsules 4 times a day for 1 week and repeated in the 3rd, 5th, and 7th week with no drug during the intervening period. The other 10 patients (5 males and 5females, age 34.4 [+ or -] 14.41 years) were given placebo capsules (resembling 2,3-dimercapto-1-propanesulfonate) in the same schedule. The consumption of arsenic-contaminated water was terminated by all 21 subjects. Initial and posttreatment urinary arsenic excretion was determined in all cases. Sequential excretion of urinary arsenic was determined during the treatment of 2 drug- and 1 placebo-treated cases. The clinical features were evaluated by an objective scoring system before and after treatment. Routine investigation including liver function test and skin biopsy were also done before and after the treatment. Drug-associated toxicity was tabulated. Results: Therapy with 2,3-dimercapto-1-propanesulfonate caused significant improvement in the clinical condition of chronic arsenicosis patients as evidenced by significant reduction of total clinical scores from 8.90 [+ or -] 2.84 to 3.27 [+ or -] 1.73; p < 0.0001. Exposure cessation alone with placebo treatment also reduced clinical scores (8.50 [+ or -] 1.96 to 5.40 [+ or -] 2.12; p < 0.003), but the posttreatment total clinical score of 2,3-dimercapto-1-propanesulfonate-treated patients (3.27 [+ or -] 1.73) was significant(v lower than that of placebo-treated patients (5.40 [+ or -] 2.12; p < 0.01). The most significant improvement was noted in regard to the clinical scores of weakness, pigmentation, and lung disease. No difference was noted between groups in the hematological and biochemical parameters (which were normal) and skin histology before and after treatment. No 2,3-dimercapto-1-propanesulfimate-related adverse effects were noted. Total urinary excretion of arsenic in 2,3-dimercapto-1-propanesulfonate-treated cases increased significantly following drug therapy, with no increase in placebo-treated cases. Conclusion: 2,3-Dimercapto-1-propanesulfonate treatment caused significant improvement in the clinical score of patients suffering from chronic arsenic toxicity. Increased urinary excretion of arsenic during the period of therapy is the possible cause of this improvement., BACKGROUND Chronic arsenic (As) toxicity due to drinking of As-contaminated water has been reported from many countries, but the number of affected people in West Bengal, India, and Bangladesh is [...]
- Published
- 2001
31. Treatment of anticholinergic-induced ileus with neostigmine. (Case Report)
- Author
-
Isbister, Geoffrey K., Oakley, Patrick, Whyte, Ian, and Dawson, Andrew
- Subjects
Parasympatholytic agents -- Adverse and side effects ,Drugs -- Overdose ,Neostigmine -- Health aspects ,Poisoning, Accidental -- Care and treatment ,Health - Published
- 2001
32. Accidental poisoning in children: can we admit fewer children with safety?
- Author
-
Sibert, J.R. and Routledge, P.A.
- Subjects
Pediatric toxicology -- Reports ,Poisoning, Accidental -- Care and treatment - Published
- 1991
33. A controlled trial of corticosteroids in children with corrosive injury of the esophagus
- Author
-
Anderson, Kathryn D., Rouse, Thomas M., and Randolph, Judson G.
- Subjects
Children's accidents -- Complications ,Esophagus -- Stenosis ,Burns and scalds -- Care and treatment ,Poisoning, Accidental -- Care and treatment ,Poisoning, Accidental -- Complications ,Steroids (Drugs) -- Evaluation - Abstract
Many cleaners used in the home are caustic, and can cause serious and even fatal injury if ingested. Even though public awareness has been raised and containers have been designed to be childproof, accidental poisonings of young children continue to occur. One serious effect of swallowing caustic substances is burning of the esophagus, the muscular tube that carries food from the mouth to the stomach. These burns can lead to strictures of the esophagus, which involve constriction, or narrowing, of the passageway. A major goal of medical intervention in these cases is to prevent strictures from developing. Methods of treatment have changed in the past 20 years, and the best approach has not yet been determined. Treatments include dilation of the esophagus, the use of stents or tubes to hold the esophagus open, and corticosteroid medications, which are thought to reduce the inflammatory response. The value of steroids in preventing strictures after ingestion of caustic substances was assessed in this study. Over an 18-year period, 60 children were assigned to either receive or not receive steroid therapy after esophageal injury from a caustic substance. The average patient age was two years. The steroid regimen began with intravenous prednisolone, which was replaced with oral prednisone for a total of three weeks. There was no difference between groups in the percentage of children who developed strictures (about one-third in each group) or the percentage who needed esophageal replacement. It was concluded that strictures developed in children with the most severe injuries, and steroids had preventative benefits. (Consumer Summary produced by Reliance Medical Information, Inc.)
- Published
- 1990
34. Repeated oral administration of activated charcoal for treating aspirin overdose in young children
- Author
-
Vertrees, Julia E., McWilliams, Bennie C., and Kelly, H. William
- Subjects
Charcoal -- Health aspects ,Antidotes -- Evaluation ,Poisoning, Accidental -- Care and treatment ,Aspirin -- Health aspects ,Carbon, Activated -- Health aspects - Abstract
Aspirin poisoning in young children is a relatively common occurrence. The probability of severe illness and death in these cases increases as the amount of aspirin swallowed and the amount of time before it is excreted increases. It is therefore very important to speed up the rate of excretion as much as possible. A common way to help the child excrete aspirin, an acid, is to give treatments of bicarbonate, an alkaline substance, and also to force fluids, although this second approach can cause severe side effects. Previously, case histories were reported in which adults and two adolescents who had aspirin poisoning were treated with some success using activated charcoal given orally. Two children under the age of two are described here; they were treated with charcoal, in addition to bicarbonate, with apparently improved aspirin excretion compared with the expected results of bicarbonate alone. Excretion was determined by measuring the reduction in the amount of aspirin in the blood during the 30 hours of charcoal treatment. The changes in blood aspirin levels were compared with those reported in other cases, and in these two children, the levels dropped more rapidly. These results, if found to be generally true in cases of aspirin poisoning, suggest that less illness and death may result from such poisoning if treatment with activated charcoal is used. (Consumer Summary produced by Reliance Medical Information, Inc.)
- Published
- 1990
35. Case series of Thermopsis exposures
- Author
-
McGrath-Hill, Cheryl A. and Vicas, Ingrid M.
- Subjects
Poisonous plants -- Health aspects ,Poisoning, Accidental -- Care and treatment ,Environmental issues ,Health ,Pharmaceuticals and cosmetics industries - Abstract
Background: Thermopsis species have been suspected of causing livestock losses. One human case series of Thermopsis poisoning was located in the literature. We report 23 suspected cases of Thermopsis exposures, some resulting in significant toxicity. Methods: Retrospective chart review of all calls involving 'buffalo beans' received by the Regional Poison Centre from 1990-1995. Results: There was a total of 23 exposures, 21 of which involved children [is less than] 12 years of age. Amounts ingested varied as did the plant part ingested. Eighteen of the patients developed symptoms within a few hours and symptoms lasted up to 12 hours. Symptoms included vomiting (14), dizziness (S), abdominal pain (3), drowsiness (2), nausea (2), headache (1), oral irritation (1), tachycardia (1), tremors (1), and other general signs (3). Of the 23 cases, 15 were managed at home but eight were referred to a health care facility, with two requiring admission. In one of the admissions, laboratory data revealed an elevated creatine kinase which remained elevated for 48 hours. Management was symptomatic and included decontamination, fluids, and observation. Plants were not professionally identified, but were referred to by the name 'buffalo bean' or 'buffalo pea.' However, in some cases, relying on the name 'buffalo bean' lead to misidentification of the plant and possible underestimation of toxicity. Conclusion: Ingestion of Thermopsis can be associated with significant morbidity. Gastric ravage may be of value in large ingestions prior to symptoms but effectiveness of activated charcoal is questionable. Patients should be observed for several hours for symptoms and supportive treatment instituted as required., INTRODUCTION The Thermopsis species have been suspected of causing cattle and horse losses, and the seeds have been thought to be poisonous to children in Western Canada.[1] However, only one [...]
- Published
- 1997
36. Zolpidem (Ambien): a pediatric case series
- Author
-
Kurta, Denise L., Myers, Lanita B., and Krenzelok, Edward P.
- Subjects
Zolpidem -- Adverse and side effects ,Poisoning, Accidental -- Care and treatment ,Pediatric toxicology -- Case studies ,Environmental issues ,Health ,Pharmaceuticals and cosmetics industries - Abstract
Background: In 1993, the nonbenzodiazepine sedative-hypnotic zolpidem tartrate (Ambien[R]) was approved for use in the US. Zolpidem has an imidazopyridine structure and possesses a rapid onset of action and a short half-life. The toxic threshold and profile have not been well established in the pediatric population. Methods: All pediatric zolpidem exposures reported to a regional poison information center over 24 months were reviewed retrospectively from the American Association of Poison Control Centers Toxic Exposure Surveillance System data collection forms. Results: Twelve pediatric zolpidem exposures were reported. Seven were unintentional (ages 20 mon-5 y) and five were intentional misuse/suicide (ages 12-16 y). The regional poison information center was contacted within 1 h in ten cases with onset of symptoms within 10 to 60 min (mean 31.6 min). One child had no effect with 2.5 mg. As little as 5 mg caused symptoms with minor outcome in six unintentional ingestions (5-30 mg). Minor to moderate symptoms were reported 1-4 h after intentional ingestions (12.5-150 mg). The duration of symptoms in the unintentional cases ranged from less than 60 min up to 4 h (mean 2.4 h) and 6-10 h (mean 7.5 h) in the intentional exposures. Treatment consisted of observation (4), syrup of ipecac (1), lavage and activated charcoal (1), activated charcoal alone (5), and unknown (1). Conclusion: Due to the very rapid onset of central nervous system symptoms in children, emesis is not a treatment option. Supportive care, activated charcoal in large ingestions, and observation until symptoms resolve may be sufficient in most pediatric cases., INTRODUCTION Zolpidem tartrate (Ambien), an imidazopyridine derivative, was introduced in the US in 1993 as a benzodiazepine alternative for the therapeutic treatment of insomnia. The benefits of zolpidem over other [...]
- Published
- 1997
37. How to treat the poisoned patient
- Author
-
Erickson, Timothy, Goldfrank, Lewis R., Kulig, Kenneth, and Starr, Cynthia
- Subjects
Poisoning -- Care and treatment ,Emergency medicine -- Practice ,Poisoning, Accidental -- Care and treatment ,Health ,Practice ,Care and treatment - Abstract
Poisonings require a quick response. In fact, treatment often begins before you can identify the accountable toxin. Fortunately, you can usually save lives just by providing supportive care and general [...]
- Published
- 1997
38. Assessing parental utilization of the poison center: an emergency center-based survey
- Author
-
Kelly, Nancy R., Kirkland, Rebecca T., Holmes, Susan E., Ellis, Michael D., Delclos, George, and Kozinetz, Claudia A.
- Subjects
Poison control centers -- Usage ,Parents -- Surveys ,Poisoning, Accidental -- Care and treatment ,Health - Abstract
It appears that certain populations may be appropriate targets to educate about the resources available through poison control hot lines. Interviews were conducted with caretakers of 210 children admitted to the emergency room for accidental poison related injuries. Nearly half of these adults had not contacted the poison control center before going to the emergency room. Black adults and those educated in Mexico were more likely not to call poison control before going to the emergency room. Adults using the poison control center's services exhibited a greater knowledge about poison prevention than those not calling.
- Published
- 1997
39. Antidotes for methanol and ethylene glycol poisoning
- Author
-
Jacobsen, Dag and McMartin, Kenneth E.
- Subjects
Methanol -- Health aspects ,Glycols -- Health aspects ,Antidotes -- Evaluation ,Poisoning, Accidental -- Care and treatment ,Environmental issues ,Health ,Pharmaceuticals and cosmetics industries - Abstract
INTRODUCTION Methanol and ethylene glycol poisonings are closely related in that both occur because of the metabolism of an alcohol moiety via alcohol dehydrogenase (ADH) to produce the metabolites that [...]
- Published
- 1997
40. Poisoning
- Author
-
Schmitt, B.D.
- Subjects
First aid in illness and injury -- Usage ,Children -- Health aspects ,Poisoning, Accidental -- Care and treatment ,Health - Abstract
When should I call the Poison Center? Call IMMEDIATELY any time you think your child has swallowed a poison. Be prepared to answer the following questions: * What was swallowed? [...]
- Published
- 2010
41. Treatment of toad venom poisoning with digoxin-specific fab fragments
- Author
-
Brubacher, Jeffrey R., Ravidkumar, Padinjarekuttu R., Bania, Theodore, Heller, Michael B., and Hoffman, Robert S.
- Subjects
Venom -- Health aspects ,Digoxin -- Health aspects ,Poisoning, Accidental -- Care and treatment ,Health ,Care and treatment ,Health aspects - Abstract
Toxicity from toad venom poisoning is similar to digoxin toxicity and carries a high mortality rate. We report on six previously healthy men who developed vomiting and bradycardia after ingesting [...]
- Published
- 1996
42. Five year retrospective evaluation of sulfonylurea ingestion in children
- Author
-
Quadrani, Debra A., Spiller, Henry A., and Widder, Patricia
- Subjects
Sulfonylurea compounds -- Adverse and side effects ,Poisoning, Accidental -- Care and treatment ,Environmental issues ,Health ,Pharmaceuticals and cosmetics industries - Abstract
Background: Oral hypoglycemic medications are frequently used for Type II diabetes and accidental ingestions by children may occur. There are no comprehensive pediatric studies documenting poison center experiences. Study Objective: To evaluate the toxicity of oral sulfonylurea ingestion in children and the efficacy of treatments instituted in these cases. Method: Retrospective review of all ingestions of oral sulfonylureas reported to a single regional poison control center 1987-1991. Results: Ninety-three cases were identified, one to 16 years old (mean of 3.5 years). Eighty cases (86%) were less than six years of age. Of the six medications used, three, chlorpropamide, glipizide and glyburide made up 88 (95%) cases. Twenty-five patients (27%) became hypoglycemic (glucose < 60 mg/dL). The mean minimum blood glucose in these patients was 46.5 mg/dL (minimum 20 mg/dL). Time of onset of hypoglycemia ranged from 0.5 to 16 h (mean 4.3 h; median 2 h). Only four patients had the onset of chemical hypoglycemia more than four hours postexposure. Persistent hypoglycemia occurred in nine children (10%) despite intravenous glucose therapy. There were no seizures. Mean time to decontamination of patients with and without hypoglycemia was 1.4 and 1.2 h respectively. Intravenous glucose of the following concentrations was administered: 5% (40), 10% (15), 20% (1), and 50% (3). Accidental ingestion of a single tablet of chlorpropamide (250 mg), glipizide (5 mg), and glyburide (2.5 ma) each produced hypoglycemia in childrenages one to four years. Accidental ingestion of 5-10 mg glyburide produced a blood glucose of 57 mg/dL in an 11-year-old child. All patients recovered fully. There were no neurological sequelae noted. Conclusion: Children ingesting oral hypoglycemics should be admitted to a health care facility for 24 h observation. In this series a single tablet produced hypoglycemia., Correspondence: Debra Quadrani, Western New York Regional Poison Control Center, Children's Hospital of Buffalo, 219 Bryant Street, Buffalo, NY 14222. Tel: 716/878-7657; Fax: 716/878/7857. INTRODUCTION In 1995, diabetes mellitus is [...]
- Published
- 1996
43. Metobromuron/metolachlor ingestion with late onset methemoglobinemia in a pregnant woman successfully treated with methylene blue
- Author
-
Chen-Chang Yang, Sheau-Feng Hwang, Min-Min Chou, and Jou-Fang Deng
- Subjects
Herbicides -- Health aspects ,Poisoning, Accidental -- Care and treatment ,Environmental issues ,Health ,Pharmaceuticals and cosmetics industries - Abstract
Metobromuron, a substituted urea herbicide, is widely used for control of grasses and broad-leaved weeds in Taiwan. Major systemic toxicity has not been reported following poisoning. A 22-year-old woman at 36 weeks of gestation was admitted to the emergency department three hours after digestion of a mixture of 25% metobromuron and 25% metolachlor. Though stable initially, she developed central cyanosis 12 hours later. Emergent cesarean section was considered but administration of intravenous methylene blue readily reversed the cyanosis and prevented the operation. Recurrent cyanosis did not develop. Normal vaginal delivery occurred 17 days after the poisoning. Follow-up for four years revealed normal growth of the child. Metobromuron poisoning, like other urea herbicides, may cause methemoglobinemia via its hydrolysis products. Administration of methylene blue is effective treatment and should be considered in the treatment of methemoglobinemia following urea herbicide poisoning., (Key Words: metobromuron: diuron: methemoelobinemia; methylene blue; metolachlor: pregnancy.) INTRODUCTION Metobromuron, a substituted urea herbicide, is effective against grasses and broad-leaved weeds. Though widely used, its effects in humans are [...]
- Published
- 1995
44. The relative efficacy of antidotes
- Author
-
Jacobsen, Dag
- Subjects
Antidotes -- Evaluation ,Poisoning, Accidental -- Care and treatment ,Environmental issues ,Health ,Pharmaceuticals and cosmetics industries - Abstract
For many physicians an antidote is an antidote. According to the International Programme on Chemical Safety definition, an antidote is a therapeutic substance used to counteract the toxic action(s) of a specified xenobiolic. Given this wide definition, the efficacy of an antidote may vary considerably depending on which toxic action(s) being counteracted and the level of counteracting power. An almost 100% efficacy is seen using specific antagonists, such as naloxone in opiate poisoning or flumazenil in benzodiazepine poisoning, e.g. resulting in complete reversal of opiate toxicity unless complications, such as anoxic brain damage, have developed. At the other end of the efficacy scale, we may place chelating agents for heavy metal poisoning and diazepam for organophosphorus insecticide poisoning which are considered only to be an adjuncts to supportive care. When teaching clinical toxicology or recommending the use of antidotes in poisoned patients, the expected efficacy level of the antidote in question should be stressed. This may be particularly important in severe poisonings when the antidote may only be considered as an important adjunct to supportive care, e.g. deferoxamine in acute iron poisoning. Unless this is stressed, the unexperienced physician may rely too much on the antidote and pay insufficient attention to the supportive care. The varying efficacy levels will be discussed based on the presently ongoing International Programme on Chemical Safety/Commission of the European Communities evaluation program on antidotes., INTRODUCTION Antidotes may play an important role in the treatment of poisoning. While good supportive care and elimination techniques may, in many cases, restore a poisoned patient to good health [...]
- Published
- 1995
45. Beneficial effect of digoxin-specific fab antibody fragments in oleander intoxication
- Author
-
Safadi, Rifaat, Levy, Izhar, Amitai, Yona, and Caraco, Yoseph
- Subjects
Poisonous plants -- Health aspects ,Digoxin -- Health aspects ,Poisoning, Accidental -- Care and treatment ,Health - Abstract
A 24-year-old man presented to the emergency department with nausea, vomiting, abdominal pain, and an acute confusional state of 6 hours' duration. Ten hours before admission, he had ingested a mixture of orange juice and six ground leaves, later identified as Nerium oleander (common pink oleander) leaves. His blood pressure was 100/80 mm Hg, and his pulse rate was irregular at 40/min. He was disoriented and his speech was dysarthric. Twelve-lead electrocardiography revealed a complete atrioventricular block, with a nodal escape rhythm of 40/min and diffuse ST depression. The presumptive diagnosis of acute oleander intoxication was confirmed by the detection of digoxin (1.0 nmol/L [0.8 ng/ml]) on radioimmunoassay. Despite intensive therapy, the patient's hemodynamic condition deteriorated. His blood pressure decreased to 70/40 mm Hg; he became oliguric and nonresponsive to external stimuli; and his potassium concentration rose to 6.8 mmol/L. Eighteen hours after admission, an empiric 480-mg dose of digoxin-specific Fab antibody fragments was administered intravenously over 30 minutes. Within minutes of the initiation of immunotherapy, the patient woke up; his blood pressure rose to 90/50 mm Hg; and he regained a sinus rhythm of 68/min with a prolonged PR interval. His potassium concentration decreased to 5.1 mmol/L within 15 minutes and normalized within 1 hour of therapy initiation. One day later, the 1[degree] atrioventricular block disappeared, but the ST depression persisted for an additional 6 days. The value of digoxin-specific Fab antibody fragments in the treatment of plant glycoside and, in particular, oleander intoxication is discussed. (Arch Intern Med. 1995; 155:2121-2125)
- Published
- 1995
46. The effect of oral deferoxamine on iron absorption in humans
- Author
-
Jackson, Tracy W., Ling, Louis J., and Washington, Vindell
- Subjects
Deferoxamine -- Physiological aspects ,Iron -- Physiological aspects ,Poisoning, Accidental -- Care and treatment ,Environmental issues ,Health ,Pharmaceuticals and cosmetics industries - Abstract
Acute iron overdose is a serious cause of morbidity and mortality, however, optimal gastric decontamination procedures in iron overdose are unclear. In order to determine the effectiveness of oral deferoxamine mesylate solution in humans to prevent the absorption of iron in acute exposures, the following prospective case control crossover study was designed. Seven informed adult human volunteers were given an oral dose of 5 mg/kg elemental iron alone in a control phase and again in an experimental phase followed by a single equimolar dose of oral buffered deferoxamine solution. Plasma iron concentrations were determined spectrophotometrically for eight hours following administration of iron alone and following doses of iron with deferoxamine. There was no significant difference in peak iron concentration, time to peak iron concentration or area-under-the-curve between the two groups. Based on our results, equimolar doses of oral deferoxamine do not appear to decrease the absorption of low doses of oral iron in humans., (Key Words: deferoxamine; iron, poisoning; gastric decontamination.) INTRODUCTION Acute overdose with iron preparations has been recognized as a serious cause of morbidity and mortality (1)(2)(3)(4)(5), especially in children (1). According [...]
- Published
- 1995
47. Ryan's last chance
- Author
-
Deane, Barbara
- Subjects
Children's accidents -- Case studies ,Poisoning, Accidental -- Care and treatment - Published
- 1995
48. Survival after a severe iron poisoning treated with intermittent infusions of deferoxamine
- Author
-
Cheney, Karla, Gumbiner, Carl, Benson, Blaine, and Tenebein, Milton
- Subjects
Iron -- Health aspects ,Poisoning, Accidental -- Care and treatment ,Deferoxamine -- Usage ,Environmental issues ,Health ,Pharmaceuticals and cosmetics industries - Abstract
Iron poisoning is the most common cause of overdose mortality in children under six years of age and there are no reports of survival with iron levels > 2687 [mu]mol/L (>15,000,[mu]g/dL). A 22-month-old male was brought to the emergency department by his parents after ingesting an estimated 50 ferrous sulfate tablets (60 mg elemental iron/tablet) several hours earlier. Despite spontaneous emesis and gastric lavage his condition deteriorated and he was found to have a serum iron of 2992 [mu]mol/L (16,706;[mu]/dL). During the first four days in the intensive care unit, he developed coma, metabolic acidosis, hypovolemic and cardiogenic shock, liver failure, coagulopathy and adult respiratory distress syndrome. He was treated with a unique deferoxamine dosage schedule (25 mg/kg/h for 12 h/d x 3 d), mechanical ventilation, Swan-Ganz catheter monitoring, dopamine/nitroprusside therapy, blood product, bicarbonate, electrolyte and volume replacement. After a prolonged hospital course complicated primarily by gastric outlet obstruction he was dismissed on full oral feedings, gaining weight, and neurologically intact. Swan-Ganz catheter monitoring guided the management of this patient's shock, iron-induced cardiac failure, and deferoxamine mesylate induced adult respiratory distress syndrome. Further experience and research is required to determine the most appropriate deferoxamine mesylate dosing schedule and our experience expands the range for possible survival after massive iron overdose. (Key Words: iron poisoning: deferoxamine: cardiogenic shock; ARDS.), INTRODUCTION Prenatal iron supplements are commonly found in the homes of young children, so it is not surprising that poisoning from such preparations is a common occurrence in children. In [...]
- Published
- 1995
49. Urginea maritima (squill) toxicity
- Author
-
Tuncok, Yesim, Kozan, Omer, Cavdar, Caner, Guven, Hulya, and Fowler, John
- Subjects
Cardiac glycosides -- Adverse and side effects ,Medicinal plants -- Health aspects ,Poisoning, Accidental -- Care and treatment ,Environmental issues ,Health ,Pharmaceuticals and cosmetics industries - Abstract
A 55 year-old female ingested two bulbs of Urginea maritime (squill) plant as a folk remedy for her arthritic pains. Her past history was significant for Hashimoto thyroiditis and she was hypothyroid upon presentation. Subsequent effects resembling those seen with cardiac glycoside intoxication included nausea, vomiting, seizures, hyperkalemia, atrioventricular block and ventricular arrhythmias resembling digitalis toxicity. A serum digoxin level by an enzyme immunoassay method was 1.59 ng/mL. Despite supportive treatment and pacing, the patient expired from ventricular arrhythmias 30 h after ingestion. Squill has been recognized since antiquity for the clinical toxicity of its cardiac glycosides, but this appears to be the first report of a fatality since 1966. (Key Words: squill: uriginea maritima: cardiac glycosides: poisoning.), INTRODUCTION The most important plant sources of cardiac glycosides are digitalis (foxglove), strophanthus and squill. Squill is Urginea maritima, the sea onion which grows near the Mediterranean shore and in [...]
- Published
- 1995
50. Aluminum phosphide poisoning - a review
- Author
-
Gupta, Sanjay and Ahlawat, Sushil K.
- Subjects
Aluminum -- Health aspects ,Ammonium compounds -- Health aspects ,Poisoning, Accidental -- Care and treatment ,Environmental issues ,Health ,Pharmaceuticals and cosmetics industries - Abstract
Aluminum phosphide poisoning is common in the rural belt of Northern India. The release of cytotoxic phosphine gas primarily affects the heart, lungs, gastrointestinal tract and kidneys, although all organs can be involved. The cellular site of action phosphine requires further definition. Diagnosis is made by clinical suspicion, silver nitrate test and biochemical examination of the gastric aspirate and viscera. Treatment consists of early gastric lavage, vasopressors and supportive care. Specific therapy with intravenous magnesium sulphate is recommended., INTRODUCTION Tablet and pellets composed of aluminum phosphide (AlP) ammonium carbonate are used worldwide against rodents and other pests which infest stored grain. In the last few years, an epidemic [...]
- Published
- 1995
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.